
|Videos|October 6, 2017
What Are the Results of the REVIVE-2 Trial?
Author(s)Contagion® Editorial Staff
David Huang, PhD, MD, shares the recent results of the REVIVE-2 trial.
Advertisement
David Huang, PhD, MD, chief medical officer at Motif Bio, shares the recent results of the REVIVE-2 trial.
Advertisement
Advertisement
Advertisement
Trending on Contagion Live
1
Reductions in Funding, Personnel Will Leave US Less Prepared for Future Infectious Disease Outbreaks
2
Invivyd doses first participants in phase 3 COVID-19 trial of VYD2311
3
ASM Initiative Aims to Advance Phage Therapy for Drug-Resistant Infections
4
Challenges to Adopting New Therapeutics: Familiarity, Diagnostics, and Real-World Use in Persistent Bacteremia
5









































































































































































